JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,340,000 | -67.2% | 572,829 | -57.5% | 100.00% | +13.1% |
Q2 2022 | $4,084,000 | -55.4% | 1,347,829 | 0.0% | 88.46% | -5.3% |
Q1 2022 | $9,152,000 | -59.4% | 1,347,829 | -50.0% | 93.42% | +0.3% |
Q4 2021 | $22,527,000 | +12.4% | 2,697,829 | 0.0% | 93.16% | +4.9% |
Q3 2021 | $20,045,000 | -33.7% | 2,697,829 | -39.3% | 88.84% | -0.5% |
Q2 2021 | $30,245,000 | -54.7% | 4,447,829 | -31.6% | 89.29% | +111.6% |
Q1 2021 | $66,759,000 | +3.7% | 6,500,349 | -29.3% | 42.19% | -6.0% |
Q4 2020 | $64,402,000 | -22.9% | 9,200,349 | -10.1% | 44.86% | -17.2% |
Q3 2020 | $83,480,000 | +18.3% | 10,230,349 | 0.0% | 54.19% | +3.8% |
Q2 2020 | $70,589,000 | +45.3% | 10,230,349 | 0.0% | 52.18% | -0.0% |
Q1 2020 | $48,594,000 | -45.6% | 10,230,349 | 0.0% | 52.19% | -43.4% |
Q4 2019 | $89,311,000 | +162.2% | 10,230,349 | 0.0% | 92.14% | +21.9% |
Q3 2019 | $34,067,000 | -32.7% | 10,230,349 | 0.0% | 75.60% | -7.4% |
Q2 2019 | $50,640,000 | -20.2% | 10,230,349 | 0.0% | 81.68% | +97.5% |
Q1 2019 | $63,428,000 | +84.0% | 10,230,349 | 0.0% | 41.36% | +20.7% |
Q4 2018 | $34,476,000 | -48.2% | 10,230,349 | 0.0% | 34.26% | -12.2% |
Q3 2018 | $66,497,000 | -15.1% | 10,230,349 | 0.0% | 39.04% | -12.1% |
Q2 2018 | $78,364,000 | -65.7% | 10,230,349 | 0.0% | 44.43% | +3.7% |
Q1 2018 | $228,648,000 | +75.3% | 10,230,349 | 0.0% | 42.85% | +82.4% |
Q4 2017 | $130,437,000 | – | 10,230,349 | – | 23.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 1,347,829 | $4,084,000 | 88.46% |
Ally Bridge Group (NY) LLC | 550,000 | $1,667,000 | 1.52% |
TRV GP III, LLC | 1,148,780 | $3,481,000 | 1.42% |
Deep Track Capital, LP | 4,259,653 | $12,907,000 | 0.85% |
COWEN AND COMPANY, LLC | 2,843,149 | $8,615,000 | 0.83% |
PFM Health Sciences, LP | 3,949,668 | $11,967,000 | 0.46% |
RTW INVESTMENTS, LP | 4,358,433 | $13,206,000 | 0.34% |
Omega Fund Management, LLC | 275,513 | $835,000 | 0.27% |
Sofinnova Investments, Inc. | 981,928 | $2,975,000 | 0.25% |
Orbimed Advisors | 2,928,900 | $8,875,000 | 0.16% |